Tom Wandless
Corporate Officer/Principal presso Obsidian Therapeutics, Inc.
Provenienza dei contatti di primo grado di Tom Wandless
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA.
13
| Holding Company | Biotechnology | 13 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Tom Wandless tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Human Resources Officer | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
VERICEL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
Marsico Capital Management LLC
Marsico Capital Management LLC Investment ManagersFinance Marsico Capital Management LLC (MCM) is a SEC-registered investment advisor and mutual fund manager headquartered in Denver, Colorado. The firm was founded by Thomas “Tom” Marsico in 1997. MCM manages assets for mutual funds, corporate retirement plans, endowments, foundations, family offices, separately managed wrap programs, and other clients. The firm also serves as the investment adviser to the Marsico Funds. | Investment Managers | Analyst-Equity | |
Vertex Venture Holdings Ltd
Vertex Venture Holdings Ltd Investment ManagersFinance Vertex Venture Holdings Ltd (Vertex Venture) is a venture capital firm subsidiary of Singapore technologies pte Ltd founded in 1988. The firm is headquartered in Singapore. | Investment Managers | Private Equity Investor | |
TOUCHSTONE INNOVATIONS PLC | Investment Managers | Corporate Officer/Principal | |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Nuvaira, Inc.
Nuvaira, Inc. Electronic Equipment/InstrumentsElectronic Technology Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN. | Electronic Equipment/Instruments | Director/Board Member | |
National University of Singapore | College/University | Doctorate Degree | |
University of Oxford | College/University | Graduate Degree Doctorate Degree | |
University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Golden Gate University | College/University | Masters Business Admin | |
St. Mary's College (Maryland) | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
IP2IPO Innovations Ltd.
IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Medical Specialties | Director of Finance/CFO | |
Vertex Management, Inc.
Vertex Management, Inc. Investment ManagersFinance Vertex Management, Inc. engages in the provision of investment management services. The company is headquartered in Singapore. | Investment Managers | Director/Board Member | |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Director/Board Member | |
Stanmore Implants Worldwide Ltd.
Stanmore Implants Worldwide Ltd. Medical SpecialtiesHealth Technology Stanmore Implants Worldwide, Ltd. designs and manufactures bespoke and modular implants for limb sparing and complex joint replacement. It provides massive endoprothesis tumour systems for orthopedic skeletal locations including the femur, tibia, knee, pelvis and humerus. The firm also offers computer assisted orthopedic surgeries. The company was founded on February 19, 1996 and is headquartered in Elstree, the United Kingdom. | Medical Specialties | Director/Board Member | |
University of Maryland School of Medicine | College/University | Doctorate Degree | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Nascient Ltd.
Nascient Ltd. BiotechnologyHealth Technology Nascient Ltd. develops a novel antibody treatment for rheumatoid arthritis. The company was founded by Phil Bland-Ward, Kim Midwood and Nigel Robert Burns in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Chief Operating Officer | |
Columbia Business School | College/University | Masters Business Admin | |
CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree | |
GENERATION BIO CO. | Pharmaceuticals: Major | Director of Finance/CFO | |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Director/Board Member | |
BOUNDLESS BIO, INC. | Biotechnology | Director/Board Member | |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Lassen Therapeutics LLC operates as a therapeutic antibody company. It discovers and develops novel medicines to treat serious unmet medical needs. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
BIOMX INC. | Biotechnology | Director/Board Member | |
Acerta Pharma LLC | Chief Operating Officer | ||
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 32 |
Regno Unito | 12 |
Singapore | 4 |
Israele | 3 |
Paesi Bassi | 2 |
Settori
Health Technology | 26 |
Finance | 10 |
Consumer Services | 10 |
Commercial Services | 3 |
Electronic Technology | 2 |
Posizioni
Director/Board Member | 71 |
Corporate Officer/Principal | 22 |
Independent Dir/Board Member | 18 |
Chairman | 13 |
Chief Executive Officer | 10 |
Contatti più connessi
Insiders | |
---|---|
Peter Barrett | 38 |
Maria Fardis | 15 |
Michael Gilman | 14 |
Robert Woodman | 14 |
Virginia R. Dean | 12 |
Heidi Hagen | 12 |
Anders Götzsche | 11 |
Jason Gardner | 10 |
Carolyn Ng | 10 |
Matthew Norkunas | 7 |
Robert Ross | 7 |
Melanie Call | 1 |
Chris Klebanoff | 1 |
- Borsa valori
- Insiders
- Tom Wandless
- Connessioni Società